Browse > Article
http://dx.doi.org/10.3344/kjp.2017.30.1.3

Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis  

Kim, Hyun Jung (Department of Preventive Medicine, College of Medicine, Korea University)
Ahn, Hyeong Sik (Department of Preventive Medicine, College of Medicine, Korea University)
Lee, Jae Young (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Choi, Seong Soo (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Cheong, Yu Seon (Department of Anesthesiology and Pain Medicine, Kangwon National University Hospital)
Kwon, Koo (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Yoon, Syn Hae (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Leem, Jeong Gill (Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Publication Information
The Korean Journal of Pain / v.30, no.1, 2017 , pp. 3-17 More about this Journal
Abstract
Background: Postherpetic neuralgia (PHN) is a common and painful complication of acute herpes zoster. In some cases, it is refractory to medical treatment. Preventing its occurrence is an important issue. We hypothesized that applying nerve blocks during the acute phase of herpes zoster could reduce PHN incidence by attenuating central sensitization and minimizing nerve damage and the anti-inflammatory effects of local anesthetics and steroids. Methods: This systematic review and meta-analysis evaluates the efficacy of using nerve blocks to prevent PHN. We searched the MEDLINE, EMBASE, Cochrane Library, ClinicalTrials.gov and KoreaMed databases without language restrictions on April, 30 2014. We included all randomized controlled trials performed within 3 weeks after the onset of herpes zoster in order to compare nerve blocks vs active placebo and standard therapy. Results: Nine trials were included in this systematic review and meta-analysis. Nerve blocks reduced the duration of herpes zoster-related pain and PHN incidence of at 3, 6, and 12 months after final intervention. Stellate ganglion block and single epidural injection did not achieve positive outcomes, but administering paravertebral blockage and continuous/repeated epidural blocks reduced PHN incidence at 3 months. None of the included trials reported clinically meaningful serious adverse events. Conclusions: Applying nerve blocks during the acute phase of the herpes zoster shortens the duration of zoster-related pain, and somatic blocks (including paravertebral and repeated/continuous epidural blocks) are recommended to prevent PHN. In future studies, consensus-based PHN definitions, clinical cutoff points that define successful treatment outcomes and standardized outcome-assessment tools will be needed.
Keywords
Epidural block; Herpes zoster; Nerve block; Paravertebral block; Postherpetic neuralgia; Stellate ganglion block;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Tajima K, Kawagoe I, Kanai M, Mitsuhata H. Effective treatment of acute pain and related symptoms in elderly with herpes zoster. Masui 2008; 57: 874-8.
2 Rutgers MJ, Dirksen R. The prevention of postherpetic neuralgia: a retrospective view of patients treated in the acute phase of herpes zoster. Br J Clin Pract 1988; 42: 412-4.
3 Manabe H, Dan K, Hirata K, Hori K, Shono S, Tateshi S, et al. Optimum pain relief with continuous epidural infusion of local anesthetics shortens the duration of zoster-associated pain. Clin J Pain 2004; 20: 302-8.   DOI
4 Higa K, Hori K, Harasawa I, Hirata K, Dan K. High thoracic epidural block relieves acute herpetic pain involving the trigeminal and cervical regions: comparison with effects of stellate ganglion block. Reg Anesth Pain Med 1998; 23:25-9.
5 Koh WS, Park SM, Kim BS, Shin DY. The effect of sympathetic blocks in the prevention of postherpetic neuralgia. Korean J Dermatol 1997; 35: 620-6.
6 Dworkin RH, O'Connor AB, Kent J, Mackey SC, Raja SN, Stacey BR, et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain 2013; 154:2249-61.   DOI
7 Gabutti G, Serenelli C, Cavallaro A, Ragni P. Herpes zoster associated hospital admissions in Italy: review of the hospital discharge forms. Int J Environ Res Public Health 2009; 6: 2344-53.   DOI
8 Gil A, Gil R, Alvaro A, San Martin M, Gonzalez A. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004). BMC Infect Dis 2009; 9:55.   DOI
9 Opstelten W, Zuithoff NP, van Essen GA, van Loon AM, van Wijck AJ, Kalkman CJ, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain 2007; 132 Suppl 1: S52-9.   DOI
10 Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010; 10: 230.   DOI
11 Bicket MC, Gupta A, Brown CH 4th, Cohen SP. Epidural injections for spinal pain: a systematic review and meta-analysis evaluating the "control" injections in randomized controlled trials. Anesthesiology 2013; 119: 907-31.   DOI
12 Manchikanti L, Cash KA, Pampati V, Malla Y. Two-year follow-up results of fluoroscopic cervical epidural injections in chronic axial or discogenic neck pain: a randomized, double-blind, controlled trial. Int J Med Sci 2014; 11: 309-20.   DOI
13 Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database Syst Rev 2010: CD003974.
14 Head H, Campbell AW, Kennedy PG. The pathology of herpes zoster and its bearing on sensory localisation. Rev Med Virol 1997; 7: 131-43.   DOI
15 Arvin A. Aging, immunity, and the varicella-zoster virus. N Engl J Med 2005; 352: 2266-7.   DOI
16 Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain 2008; 9: S3-9.   DOI
17 Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996; 67: 241-51.   DOI
18 Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014; 4: e004833.   DOI
19 Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271-84.   DOI
20 Chen N, Li Q, Yang J, Zhou M, Zhou D, He L. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2014: CD006866.
21 Nahm FS, Kim SH, Kim HS, Shin JW, Yoo SH, Yoon MH, et al. Survey on the treatment of postherpetic neuralgia in Korea; multicenter study of 1,414 patients. Korean J Pain 2013; 26: 21-6.   DOI
22 Sacks GM. Unmet need in the treatment of postherpetic neuralgia. Am J Manag Care 2013; 19: S207-13.
23 Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain 2002; 18: 350-4.   DOI
24 Eaglstein WH, Katz R, Brown JA. The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster. JAMA 1970; 211: 1681-3.   DOI
25 Levin MJ, Gershon AA, Dworkin RH, Brisson M, Stanberry L. Prevention strategies for herpes zoster and post-herpetic neuralgia. J Clin Virol 2010; 48 Suppl 1: S14-9.   DOI
26 Klenerman P, Luzzi GA. Acyclovir and postherpetic neuralgia. Biomed Pharmacother 1990; 44: 455-9.   DOI
27 Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2011: CD007795.
28 Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev 2013: CD005582.
29 Opstelten W, van Wijck AJ, Stolker RJ. Interventions to prevent postherpetic neuralgia: cutaneous and percutaneous techniques. Pain 2004; 107: 202-6.   DOI
30 Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain 2000; 87: 121-9.   DOI
31 Doran C, Yi X. The anti-inflammatory effect of local anesthetics. Pain Clin 2007; 19: 207-13.   DOI
32 Yanagida H, Suwa K, Corssen G. No prophylactic effect of early sympathetic blockade on postherpetic neuralgia. Anesthesiology 1987; 66: 73-6.   DOI
33 Riopelle JM, Naraghi M, Grush KP. Chronic neuralgia incidence following local anesthetic therapy for herpes zoster. Arch Dermatol 1984; 120: 747-50.   DOI
34 Tajima K, Iseki M, Inada E, Miyazaki T. The effects of early nerve blocks for prevention of postherpetic neuralgia and analysis of prognostic factors. Masui 2009; 58: 153-9.
35 Winnie AP, Hartwell PW. Relationship between time of treatment of acute herpes zoster with sympathetic blockade and prevention of post-herpetic neuralgia: clinical support for a new theory of the mechanism by which sympathetic blockade provides therapeutic benefit. Reg Anesth 1993;18: 277-82.
36 Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Oxford, The Cochrane Collaboration. 2011.
37 Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8:336-41.   DOI
38 Bhala BB, Ramamoorthy C, Bowsher D, Yelnoorker KN. Shingles and postherpetic neuralgia. Clin J Pain 1988; 4:169-74.   DOI
39 Ahn SY, Lee YB, Lee KH, Lim HK, Lee WS, Ahn SK, et al. The effect of stellate ganglion block on herpes zoster. Korean J Dermatol 2006; 44: 681-7.
40 Tenicela R, Lovasik D, Eaglstein W. Treatment of herpes zoster with sympathetic blocks. Clin J Pain 1985; 1: 63-7.   DOI
41 Hwang SM, Kang YC, Lee YB, Yoon KB, Ahn SK, Choi EH. The effects of epidural blockade on the acute pain in herpes zoster. Arch Dermatol 1999; 135: 1359-64.
42 Ji G, Niu J, Shi Y, Hou L, Lu Y, Xiong L. The effectiveness of repetitive paravertebral injections with local anesthetics and steroids for the prevention of postherpetic neuralgia in patients with acute herpes zoster. Anesth Analg 2009; 109:1651-5.   DOI
43 Lee IH, Kim BS, Lee SC, Jo DH. The effect of stellate ganglion block on the pain of acute stage and the prevention of postherpetic neuralgin in the treatment of senile herpes zoster patients. Korean J Dermatol 1999; 37: 571-9.
44 Lee YB, Park JT, Han JW, Yoon KB. The efficacy of epidural blockade on acute herpes zoster. J Korean Pain Soc 1999; 12: 183-7.
45 Lipton JR, Harding SP, Wells JC. The effect of early stellate ganglion block on postherpetic neuralgia in herpes zoster ophthalmicus. Pain Clin 1987; 1: 247-51.
46 Makharita MY, Amr YM, El-Bayoumy Y. Effect of early stellate ganglion blockade for facial pain from acute herpes zoster and incidence of postherpetic neuralgia. Pain Physician 2012; 15: 467-74.
47 Makharita MY, Amr YM, El-Bayoumy Y. Single paravertebral injection for acute thoracic herpes zoster: a randomized controlled trial. Pain Pract 2015; 15: 229-35.   DOI
48 Pasqualucci A, Pasqualucci V, Galla F, De Angelis V, Marzocchi V, Colussi R, et al. Prevention of post-herpetic neuralgia: acyclovir and prednisolone versus epidural local anesthetic and methylprednisolone. Acta Anaesthesiol Scand 2000; 44: 910-8.   DOI
49 van Wijck AJ, Opstelten W, Moons KG, van Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet 2006; 367:219-24.   DOI